Tocagen Inc. (TOCA) financial statements (2021 and earlier)

Company profile

Business Address 4242 CAMPUS POINT COURT, SUITE 500
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:229689
Cash and cash equivalents94136
Short-term investments135553
Other undisclosed cash, cash equivalents, and short-term investments(0)0 
Other undisclosed current assets122
Total current assets:239891
Noncurrent Assets
Operating lease, right-of-use asset4
Property, plant and equipment241
Other noncurrent assets 10
Total noncurrent assets:551
TOTAL ASSETS:2810392
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities81610
Accounts payable332
Accrued liabilities5138
Debt5 7
Deferred revenue and credits0
Other undisclosed current liabilities 00
Total current liabilities:131717
Noncurrent Liabilities
Long-term debt and lease obligation4264
Long-term debt, excluding current maturities 264
Operating lease, liability4
Liabilities, other than long-term debt020
Deferred revenue and credits0
Deferred rent credit 2
Other liabilities0  
Total noncurrent liabilities:4284
Total liabilities:174521
Stockholders' equity
Stockholders' equity attributable to parent115871
Common stock000
Additional paid in capital290274238
Accumulated other comprehensive income (loss)0(0)(0)
Accumulated deficit(279)(216)(167)
Total stockholders' equity:115871
TOTAL LIABILITIES AND EQUITY:2810392

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Revenue, net0
Gross profit:0180
Operating expenses(62)(64)(38)
Operating loss:(62)(46)(38)
Nonoperating expense  (1)
Interest and debt expense(4)(3)(2)
Loss from continuing operations before equity method investments, income taxes:(65)(49)(41)
Other undisclosed income from continuing operations before income taxes22 
Loss from continuing operations before income taxes:(64)(47)(41)
Income tax expense(0)(2) 
Net loss:(64)(49)(41)
Other undisclosed net income attributable to parent  2
Net loss available to common stockholders, diluted:(64)(49)(39)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Net loss:(64)(49)(41)
Other comprehensive income (loss)00(0)
Comprehensive loss:(63)(49)(41)
Other undisclosed comprehensive income, net of tax, attributable to parent  2
Comprehensive loss, net of tax, attributable to parent:(63)(49)(39)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: